From another site (part 2)25 Nov 2018 23:43
Separately, but also of exceptional value, is the company’s 68%-owned West Kytlim mine. It is the second largest alluvial PGM mine in production globally and is located in the Russian Ural Mountains. The asset achieved industrial-scale production (4,549 ounces of platinum) in May and is set to increase production sevenfold by the 2019 and 2020 seasons (to around 23,952 ounces of platinum) as mining transitions to the new Kluchiki pit.
Now, as far as valuations go, and employing basic DCF modelling, the palladium-rich Monchetundra asset comes in at a pre-production, risked valuation of £147.4m whilst the already-producing West Kytlim asset comes in at £57.2m. That said, and with market consensus continuing to forecast a supply deficit of palladium, the palladium spot price used ($1,051/oz) in the valuation of Monchetundra is likely to be viewed as conservative in the coming months. This is, in part, a reflection of the material growth being observed in the autocatalyst market which consumes around 80% of palladium demand. Thus, we believe Monchetundra will increasingly appear on the radar of major mining companies looking for quality tier 1 assets.
For the record, we exclude any valuation for the Semenovsky asset as the project remains non-core at this time.
Balance sheet wise, the company is currently debt-free with circa £351,000 cash. 166m outstanding warrants at an exercise price of 0.60p (£996,000) and 30m outstanding warrants at 1.00p (£300,000) means the company has plenty of headroom to shore-up its balance sheet without the risk of any material dilution;
• 10m warrants at 1.00p are attached to Dmitry Suschov (Director) who is likely to use the opportunity to build his stake in the business.
• 90m warrants at 0.60p are attached to Venus Garden Holdings Limited (BVI), wholly owned by Alexei Churakov, the ex-Goldman Sachs and Morgan Stanley banker, serial investor, and Russian mining tycoon. Again, an incredible stake-building opportunity.
• 20m warrants at 0.60p and 10m warrants at 1.00p are attached to Dr Michael Martineau (ex-Chairman) who is now retired.
More importantly, however, and as of November 20, 2018, the company’s directors sported some serious skin in the game with a notable 23.69% stake in the business. That said, and should they choose to exercise their recent options, this stake is likely to jump to 27.14%.
So, question; why on earth are retail investors selling a fully-funded, management-backed, state-backed (Russia), high-growth stock with a current NPV of circa £204.6m (7.97p per share fully diluted), a market cap of £17.7m (0.75p per share), and a rapidly growing acceptance that the company is now an attractive takeover target for cash-rich early movers in the Paladium space? Answer; the ‘disposition’ effect.
Thus, the revaluation of Eurasia’s shares will not wait for the formal issue of the Monchetundra mining licence, which is expected imminently anyway, as the stock is profoundly mispriced o